Abstract
Chronic functional mitral regurgitation (FMR) is a frequent finding of ischemic heart disease and dilated cardiomyopathy (DCM), associated with unfavourable prognosis. Several pathophysiologic mechanisms are involved in FMR, such as annular dilatation and dysfunction, left ventricle (LV) remodeling, dysfunction and dyssynchrony, papillary muscles displacement and dyssynchrony. The best therapeutic choice for FMR is still debated. When optimal medical treatment has already been set, a further option for cardiac resynchronization therapy (CRT) and/or surgical correction should be considered. CRT is able to contrast most of the pathophysiologic determinants of FMR by minimizing LV dyssynchrony through different mechanisms: Increasing closing forces, reducing tethering forces, reshaping annular geometry and function, correcting diastolic MR. Deformation imaging in terms of two-dimensional speckle tracking has been validated for LV dyssynchrony assessment. Radial speckle tracking and three-dimensional strain analysis appear to be the best methods to quantify intraventricular delay and to predict CRT-responders. Speckle-tracking echocardiography in patients with mitral valve regurgitation has been usually proposed for the assessment of LV and left atrial function. However it has also revealed a fundamental role of intraventricular dyssynchrony in determining FMR especially in DCM, rather than in ischemic cardiomyopathy in which MR severity seems to be more related to mitral valve deformation indexes. Furthermore speckle tracking allows the assessment of papillary muscle dyssynchrony. Therefore this technique can help to identify optimal candidates to CRT that will probably demonstrate a reduction in FMR degree and thus will experience a better outcome.
Keywords: Mitral regurgitation, Deformation imaging, 3D echocardiography, Mechanical dyssynchrony, Speckle tracking
Core tip: The epidemiologic and prognostic impact of chronic functional mitral regurgitation (FMR) is fully acknowledged. Multiple factors are involved in the pathophysiology of FMR, such as mitral valve remodeling, left ventricle (LV) remodeling and mechanical dyssynchrony. Deformation imaging by 2 dimensional speckle tracking and 3 dimensional echocardiography are the echocardiographic techniques currently used to better characterize LV dyssynchrony. Pharmacologic and cardiac resynchronization therapy is the first line-therapeutic approach to treat FMR. In case of failure of this first therapeutic approach, surgery and percutaneous treatment in high risk patients represent an alternative option.
INTRODUCTION
Chronic functional mitral regurgitation (FMR) is a frequent complication of ischemic heart disease or less frequently dilated cardiomyopathy (DCM), following left ventricular (LV) dysfunction and remodeling. Various degrees of severity of FMR are commonly described in patients with LV dysfunction despite a structurally normal valve. Indeed, according to Carpentier’s functional classification, FMR can be due to dilated mitral annulus (type I) or more often to a systolic restriction of leaflet motion (type IIIb).
The exact occurrence of FMR is difficult to assess because of different diagnostic approaches and timing of evaluation. The prevalence of FMR is nevertheless considerable, varying from 20% to 50% after myocardial infarction (MI) as assessed by echocardiographic studies[1]. This has been further confirmed by recent studies assessing long-term outcome of patients affected by heart failure associated with FMR treated with standard medical therapy[2].
Both ischemic and non-ischemic FMR are related to an unfavourable outcome in DCM[3,4], independently of the degree of ventricular dysfunction. Additionally the degree of FMR relates directly to the mortality and heart failure events. Actually, FMR is related to a decreased survival rate even if of mild degree, as MR severity positively correlates to increased mortality. An effective regurgitant orifice area > 20 mm2 has been shown to double all-cause mortality and the risk of admission for acute decompensated heart failure. Furthermore, the presence of even moderate MR increased the risk of heart failure and death by more than 3-fold and 2-fold at 5 years respectively[5].
PATHOPHYSIOLOGY
Several pathophysiologic mechanisms are involved in determining FMR. Kaul et al[6] speculated that MR resulted from global LV dysfunction, rejecting the role of dysfunction of papillary muscles and the adjacent LV myocardium in determining FMR. Further studies failed to demonstrate that LV systolic dysfunction in the absence of LV dilatation and remodeling produced significant MR, whereas leaflets tethering was the only independent predictor of MR and LV sphericity was correlated to MR grade. Certainly an imbalance between closing and tethering forces is responsible for FMR due to LV dilatation and reduction of contractility, global LV dyssynchrony, papillary muscles displacement and dyssynchrony, altered systolic mitral annular contraction[7].
Tethering is the principal determinant of FMR, because of LV remodeling associated to apical and posterior papillary muscle displacement, that lead to a reduction in closing forces.
Depending on the type of global or local LV remodeling, two tethering patterns have been described[6]: The asymmetric and symmetric ones, depending on mitral leaflets position and their point of coaptation[8] (Figure 1).
The asymmetric pattern is caused by an an asymmetrical shift of the posterior papillary muscle, determining a greater tenting of the posterior leaflet compared to the anterior one. Papillary muscle tethers the body of the anterior leaflet generating a “hockey stick” or ‘‘bent knee’’ configuration (Figure 1A and B). MV coaptation point is moved posteriorly and the anterior leaflet coapts creating a ‘‘pseudo-prolapse’’ appearance. The associated MR jet is typically eccentric, directed posteriorly in the left atrium (LA). Conversely in the symmetric pattern MV leaflet coaptation point is displaced towards the apex and both leaflets are tethered, generating a typically central MR jet (Figure 1C and D). This usually occurs in the context of a large anterior myocardial infarction, multiple infarcted area or idiopathic DCM.
Chronic FMR cause progressive LV dilation and papillary muscles displacement, leading to a further increase of tethering forces acting on mitral leaflets and, therefore, to a worsening of MR in vicious cycle.
Also conduction abnormalities, caused either by right ventricular pacing or bundle branch block, predispose to FMR. In fact the presence of intraventricular conduction determines mechanical dyssynchrony and mitral valve deformation[9].
Cardiac mechanical dyssynchrony can be distinguished in atrioventricular, inter- and intraventricular. Prolongation of the atrioventricular conduction time delays systolic ventricular contraction, hampering early diastolic filling when atrial suddenly decrease. Accordingly LV diastolic pressure exceeds atrial pressure causing diastolic mitral regurgitation. The reduction in LV preload determines a decrease in its contractility, according to Starling law.
As for inter- and intraventricular dyssynchrony, the former refers to delayed activation of LV relative to the right one, whereas the latter indicates differences in the timing of contraction of distinct myocardial segments. Both types of conduction delays cause an asynchronous contraction of LV wall (ventricular dyssynchrony), reducing stroke volume.
Mauer et al[10] first proved that significant differences in MR existed depending on the site of cardiac pacing. In particular they demonstrated in dogs that artificial stimulation through a right ventricular apical pacemaker generated a severe MR compared to a basal LV pacing within the coronary sinus.
Mechanical dyssynchrony may contribute to FMR as follows. First a decrease in MV closing forces can be determined by LV global dyssynchrony that may decrease the efficacy of LV systolic contraction[11,12]. Secondly, a geometric distortion of mitral valve apparatus may be induced by dyssynchronous contraction of the papillary muscle insertion sites[13]. Third, impaired leaflet coaptation can be enhanced by dyssynchronous contraction of LV basal segments, that may cause a papillary muscles asynchronous contraction[14] (Figure 2). The prolonged QRS duration correlates with both FMR severity and duration in patients with DCM[15,16]. Supporting this, several studies have shown that one of the positive effects of cardiac resynchronization therapy (CRT) is a decrease in FMR grade[17-20]. Soyama et al[21] analysed 32 patients affected by DCM with Tissue Doppler echocardiography showing that a dyssynchronous activation of myocardial segments adjacent to the papillary muscles could cause MR determining a non-synchronized closure of mitral leaflets. Donal et al[22] reported that MR in patients with DCM is a multifactorial and complex phenomenon, thus its accurate description should take into account LV contraction abnormalities and dyssynchrony, LV geometry and mitral orifice.
Considering LV reverse remodeling after CRT, certainly the changes in MV apparatus influence the improvement of FMR. Konstantinou et al[23] studied FMR secondary to ischemic (n = 55) and non-ischemic DCM (n = 48) and found that FMR severity is mainly determined by the degree of mitral apparatus distortion; furthermore the authors found that in these patients, a quick estimation of FMR severity could be obtained observing coaptation height. Finally, additional determinants of FMR included the presence of global LV dyssynchrony and reduced myocardial systolic velocities of the posteromedial papillary muscle insertion site.
FMR is a dynamic condition, changing dramatically with loading conditions, because of phasic fluctuations in the balance between tethering and closing forces. The increase in afterload (i.e., hypertension, exercise) worsens MR, further deforming the infarcted papillary muscles bearing segments because they promptly deforms in response to increased intraventricular pressure. On the contrary diuretic therapy, afterload decrease by vasodilators or general anaesthesia reduce FMR severity. FMR is therefore a dynamic lesion, varying through the cardiac cycle, as the regurgitant volume is greater in the early and late systolic phases, lower in the mid systole, having a beat to beat variation[24]. In addition, Ennezat et al[25] showed that rest LV dyssynchrony is associated with worsening of FMR during exertion. In this study, 20% of patients with significant LV dyssynchrony developed an exercise-induced EROA increase, whereas the rest did not have a decrease in mitral EROA during exercise[25].
DEFORMATION IMAGING
Myocardial deformation imaging is a novel echocardiographic tool that can be used to evaluate global and regional myocardial function.
The evaluation of contractile function with echocardiography has traditionally been limited to volume-based assessment of global systolic function with ejection fraction (EF) and of segmental wall motion or visual estimation of regional thickening. These methods have suffered from lack of reproducibility and standardization and are generally considered to be extremely sensitive to loading conditions. These limitations have led to an interest in techniques that provide more objective and reproducible measures of contractile function.
During systolic phase, ventricular myocardium shortens in the longitudinal and circumferential planes, while getting thicker in the radial plane. Deformation imaging allows for a more direct evaluation of myocardial changes through the cardiac cycle by speckle tracking analysis.
Myocardial deformation imaging with echocardiography can be performed with the use of either tissue Doppler-based or 2-dimensional (2D) speckle tracking-based methods. Doppler methods suffer from limitations similar to those of traditional Doppler because it can only accurately assess deformation in the plane incident with the ultrasound beam and requires prospective acquisition of dedicated images at high frame rate.
Speckle tracking analysis is obtained assessing the spatial dislocation (tracking) of speckles (spots created by the interplay between ultrasounds and myocardial fibers) on bidimensional echo. This tool offers the advantage of an objective quantitative assessment of regional and global myocardial function, not affected by insonation angle, cardiac translational movements[26-28], with a good interobserver and intraobserver reproducibility, because of its semi-automated feature[29]. Furthermore, although initially proposed only for the LV functional assessment, many authors have showed its utility for the evaluation of other cardiac structures, in particular of the LA. A recent comparison between speckle tracking derived measures and jagged MRI showed feasibility and reproducibility of this echocardiographic tool[30].
Speckle tracking analysis evaluates strain, that can be described as the systolic change in length of a myocardial segment relatively to its length at rest, so expressed as a percentage. Strain rate is also calculated as the rate of this deformation[31].
This technique has some limitations, based on the need of a good definition of the endocardial borders, therefore being highly dependent on the quality of 2D images and frame rate.
Myocardial strain can be assessed in four principal planes of deformation: Radial strain (myocardial thickening) and circumferential strain (myocardial shortening) from short-axis views; transverse (myocardial thickening) and longitudinal strains (myocardial shortening) assessed from apical views. Furthermore, speckle tracking analysis allows a complete characterization of LV rotation (occurrence, direction and velocity) during cardiac cycle[32].
Longitudinal strain describes the systolic myocardial fibers shortening from the base to the apex. This deformation is expressed in negative trend curves, obtained analysing the myocardial shortening in apical 4-chamber, 2-chamber and long axis view (Figure 3). Both regional, so for each of the 17 LV myocardial segments, and global values are computed. Global longitudinal strain value has been shown to be a quantitative index of LV systolic performance[33]. Longitudinal strain can also be applied to LA[34] and right ventricle (RV) analysis strain[35], respectively assessing the peak atrial longitudinal strain and RV longitudinal strain values.
Radial strain describes myocardial deformation directed radially towards the centre of LV cavity, represented by systolic thickening and diastolic thinning (Figure 4). Therefore, during the systolic phase radial strain curve will have positive values. Radial strain can be obtained through the analysis of parasternal short axis view, both from the basal and the apical cut[36].
Circumferential strain is also obtained from speckle tracking analysis of the parasternal short axis view[37]. It represents the LV myocardial systolic shortening along its circumference and is expressed by systolic negative curves (Figure 5). A global circumferential strain value can also be calculated.
Finally LV twisting[37], a fundamental component of LV systolic contraction, can be can be studied with speckle tracking analysis in terms of systolic reciprocal rotation of LV base and apex. LV twisting is computed as the difference between the mean rotation of the basal and the apical levels respectively, that can be the normalized for the apex-to-base distance, obtaining a “LV torsion” value[38].
Speckle tracking allows an early identification of global and segmental myocardial dysfunction, analysing the percentage of myocardial deformation that reflects the changes occurring in myocardial ultrastructure. Therefore lots of potential clinical application of this technique can be proposed, including the possibility to detect LV subclinical systolic impairment, if an alteration of longitudinal strain is discovered, for example in the setting of diabetes, coronary artery disease or valvulopathies. Several authors contributed to confirm this clinical application. Choi et al[39] studied asymptomatic patients without wall abnormalities and found that the presence of lower longitudinal strain values was a strong predictor of stable ischemic disease. Recently Voight et al[40] identified post systolic motion, after aortic valve closure, as a significant quantitative marker of the ischaemic myocardium. Further, it has been showed that with New York Heart Association (NYHA) functional class worsening from I to IV, progressively lower longitudinal strain values are observed in HF patients; in addition, in NYHA class III and IV, a systolic impairment of LV circumferential and radial strain become evident[41,42]. Stanton et al[43] studied HF patients with low EF and found global circumferential strain to be a strong predictor of cardiovascular adverse events. Furthermore, global longitudinal strain was also found to be a stronger predictor of outcome than EF in Mele et al[44] study. In low EF patients with indication to CRT, strain parameters have recently been shown to identify CRT responders with good reproducibility and accuracy[45]. In particular, dyssynchrony analysis by radial strain has been shown to effectively predict CRT efficacy[46,47].
Three-dimensional speckle tracking echocardiography (3D-STE) is the newest tool among deformation imaging and dyssynchrony analysis[48,49]. Differently from 2D speckle tracking, that analyses only a single plane and may oversimplify the complexities of LV mechanics, 3D speckle tracking takes advantage of pyramidal and strain data that include the whole LV, acquired with a matrix arrays transducer, therefore tracking speckles moving through a 3D space (Figure 6).
Acquisition of a full-volume dataset requires smaller wedge-shaped sub-volumes from at least four consecutive heart beats (asking the patient to hold the breath), automatically combined in a single larger pyramidal volume. 3D datasets are displayed in different cross-sections including standard three short-axis views and apical four- and two-chamber views that could be modified interactively. Regions of interest are placed on the endocardium and epicardium from apical views, and the software automatically divides data into 16 standard segments to generate corresponding time-strain curves[50]. 3D-STE offers the advantage of simultaneously calculating radial, circumferential and longitudinal strain values in the whole LV myocardium. Furthermore, 3D-STE could help in selection of patients who may be CRT responders as it offers an accurate mechanical dyssynchrony map, and potentially it could guide the electrophysiologists during CRT implantation, precisely localizing the site of latest myocardial activation.
ROLE OF DEFORMATION IMAGING IN MITRAL VALVE DISEASE
STE in patients with mitral valve disease has been usually performed for LV and LA functional assessment. Asymptomatic patients with severe organic MR might develop latent LV systolic impairment even if EF appears to be normal. In asymptomatic patients affected by severe MR, preoperative evidence of LV dysfunction is associated with post-operative lower long term survival and worsening of systolic function. In fact, these patients usually have lower post-operative EF, higher incidence of heart failure and mortality, as compared to patients with severe MR without LV impairment before surgery[51]. Agricola et al[52] studied patients with MR and normal EF using TDI of the mitral annulus. They found out that longitudinal function can be altered despite normal EF and that systolic TDI value can predict post-operative LV impairment. Thus TDI has been proposed as a simple, available and immediate method to early recognize LV dysfunction due to volume overload in patients with significant MR. More recently, Lancellotti et al[53] underlined that limited exercise increase of global longitudinal strain in patients with degenerative MR, candidates to cardiac surgery, predicted post-operative LV dysfunction development.
Moonen et al[54] studied patients with MR and matched healthy controls using longitudinal strain analysis with 2D speckle tracking, both at rest and during exercise. At rest global longitudinal strain was significantly lower in MR patients. During exercise, a lower increase of this value was observed in MR patients compared to control group. In addition, up a small increase of global longitudinal strain at peak exercise was shown to be a predictor LV dysfunction during follow up[54].
MR generally progresses insidiously. Patients can be asymptomatic for a long time and, as the heart compensate to the regurgitant volume with LA enlargement, interpretation of LV EF can be challenging in presence of significant MR. Later, chronic volume overload will progressive LV dysfunction, subsequently worsening outcome.
Left atrial remodeling and dilation is associated with myocardiocyte hypertrophy and interstitial fibrosis, bringing with it the risk of atrial fibrillation (AF)[55]. Furthermore, the presence of LA remodeling predicts cardiovascular events, in particular stroke, death and heart failure. Transthoracic echocardiography permits only the evaluation of LA dimensions LA that has prognostic implication[56]. However the study of regional LA function may add information about atrial electromechanical remodeling, being useful for prognostic stratification, AF risk and management[55].
LA longitudinal deformation dynamics can be assessed by speckle tracking analysis. Peak atrial longitudinal strain allows the quantification of the reservoir phase of LA, that depends on atrial compliance. In fact, during this phase, LA longitudinal strain increases, reaching a peak at the end of LA filling, just before mitral valve opening (Figure 7). Cameli et al[57] demonstrated an inverse correlation between global peak longitudinal strain (PALS) and MR degree, as lower values of PALS were observed in patients with moderate and severe MR, compared to patients with mild MR. In this study, LA myocardial reservoir function impairment was associated with an higher incidence of paroxysmal AF.
DEFORMATION IMAGING IN THE EVALUATION OF MECHANICAL DYSSYNCHRONY
Mechanical dyssynchrony can be assessed using different imaging modalities: Conventional M-Mode, Doppler echocardiography, tissue Doppler imaging (TDI) and newer modalities such as strain rate imaging (SRI) and 3D STE.
Echocardiographic evaluation of mechanical dyssynchrony has been of great interest for the identification of potential responders to CRT. Even though the largest body of publications on LV dyssynchrony and CRT response prediction is based on TDI[58,59]. However, in the PROSPECT (Predictors of Responders to Cardiac Resynchronization Therapy) trial time to peak time-to-peak dyssynchrony evaluation did not have enough predictive value to replace standard selection criteria for resynchronization therapy[60]. Also pulsed-Doppler evaluation of interventricular dyssynchrony may predict the response to CRT, but more solid evidence supports intraventricular dyssynchrony assessment by speckle tracking as a mean to identify CRT responder.
LV dyssynchrony study by speckle tracking was firstly proposed by Suffoletto et al[61]. In this study radial strain dyssynchrony analysis was performed in a cohort of 50 HF patients with standard indications to CRT. The authors found the presence of baseline significant radial dyssynchrony to be associated with a significant increase in EF at 5 to 8 mo after CRT. Furthermore a greater increase in EF was observed in patients with lead position concordant to the latest site of activation identified at the radial strain study, compared to patients with discordant lead position.
Gorcsan et al[62] studied 176 HF patients candidates to CRT with both 12-site TDI time to peak dyssynchrony analysis and radial strain. They found that 95% of patients with significant dyssynchrony both at TDI (> 60 msec) and radial strain (> 130 msec) studies showed an EF improvement, while only the 21% of patients without dyssynchrony at both tests had an EF response[62]. Based on several trials, actually a value of antero-septal to posterior wall peak delay > 130 msec is considered indicative of significant radial dyssynchrony (Figure 8). Bank et al[63] in the PROMISE-CRT trial studied HF patients with radial strain analysis and concluded that the presence of radial dyssynchrony predicted reverse remodeling after CRT. However the sample was small and so placebo effect could not be overcome. Gorcsan et al[64] then studied 197 candidates to CRT with radial strain, considering a delay > 130 msec significant for radial dyssynchrony. They found that patients with significant radial dyssynchrony before CRT had a lower incidence of adverse events [heart transplant, need for a LV assistance device (LVAD), death] at 4-year follow up, compared to patients without baseline dyssynchrony.
Most recently, in the STAR trial by Tanaka et al[65], baseline dyssynchrony assessed with both radial and transverse strain was found to be a predictor of response to CRT, in terms of EF improvement and better long term survival, as only 11%-13% of these patients died or underwent heart transplant or LVAD implantation. Patients without either radial or transverse dyssynchrony prior to CRT had a worse prognosis, as in 50% of these cases an unfavourable event occurred. On the other hand, in one third of patients responders to CRT, both longitudinal and circumferential strain failed to detect significant dyssynchrony. Thus, the authors concluded that radial and transverse strain are the most reliable methods to assess dyssynchrony and predict response to CRT. Furthermore, radial strain dyssynchrony evaluation permitted the identification of the most delayed site of LV activation. Ypenburg et al[66] studied 244 patients before CRT with 2D radial strain analysis and found that the latest site of LV activation was most frequently represented by the posterior (36%) and the lateral segments (33%). They also evidenced that if the LV lead position was concordant to the identified latest site of activation, better echocardiographic response and long term outcome could be expected after CRT.
As for longitudinal dyssynchrony, Lim et al[67] studied 100 HF patients before CRT using longitudinal strain and derived a strain delay index, that resulted to be a marker of dyssynchrony and viability or scar. They reported a strain delay index > 25% to be consistently associated with LV reverse remodeling after CRT.
Shi et al[68] studied 53 HF patients with 2D speckle tracking obtaining standard deviation of time to PALS in 12 LV segments (Tstrain-SD) and standard deviation of time to the end of longitudinal systolic strain rate in six basal LV segments (Tsr-SD). No significant difference was observed in baseline Tsr-SD, and Tstrain-SD between non-responders and responders to CRT. However, the Tsr-SD was significantly higher in responders than non-responders. Ma et al[69] found that both global and regional longitudinal strain can be predictors of long-term response to CRT in patient with ischemic cardiomyopathy. Further, baseline longitudinal strain values in the site of LV leads were consistently higher in responder patients. Finally, also baseline global longitudinal strain was found to be higher in CRT responder patients than in non-responders, with a global longitudinal strain of -13% predicting response to CRT, thus suggesting that patients with better global LV function had less scar tissue and are likely to benefit more significantly from CRT. Becker et al[70] applied circumferential strain analysis to HF patients before CRT, showing that dyssynchrony assessed by circumferential strain did not differ between CRT responders and non-responders. Of note, this trial was more focused on the effect of LV lead position on CRT response than on the role of dyssynchrony. Delgado et al[71] compared circumferential, longitudinal and radial strain and found that only dyssynchrony assessed with radial strain was able to predict CRT responders in a study group of 161 patients, while circumferential and longitudinal strain were not. As a consequence of these several trials, we can assume that LV dyssynchrony analysed with radial strain is more informative than longitudinal or circumferential strain analysis and can predict CRT responders. Furthermore, also magnetic resonance imaging studies confirmed that radial dynamics analysis can be more sensitive in identifying the presence of dyssynchrony, compared to longitudinal myocardial deformation study[72,73]. However higher global longitudinal strain and regional longitudinal strain at the site of LV lead positioning can also predict the response to CRT[74]. The dyssynchrony strain pattern evidenced by 2D speckle tracking echo is also very important to predict the response to CRT. In patients with heart failure, the presence of intraventricular dyssynchrony is usually evidenced by left bundle branch block (LBBB) at EKG. In presence of a true LBBB or right ventricular pacing, the contraction pattern is characterized by early contraction in early activated walls (septum) and pre-stretch followed by late contraction in late activated walls (lateral wall). The strain-pattern can reflect a complete LBBB in the so called “classical” pattern, that is defined by three components: (1) early activation of at least one basal or midventricular segment in the septal or anteroseptal wall and early stretching in at least one basal or midventricular segment in the opposite wall; (2) early peak contraction not exceeding 70% of the ejection phase; and (3) early stretching wall showing peak contraction after aortic valve closure. Patients who do not fulfil all these three criteria are considered having a heterogeneous strain-pattern. Risum et al[74] showed that contraction patterns reflective of a consistently delayed LV activation are predictive of response. The presence of a “classic” strain pattern strongly predicted the CRT efficacy, while other patients with wall motion patterns inconsistent with a LV activation delay were less likely to benefit. Importantly, the presence of a classical pattern significantly added to other predictors of response (etiology and QRS > 150 ms) further emphasizing a valuable role for pre-implantation assessment of mechanical dyssynchrony by speckle tracking approach.
Also apical transverse motion (ATM), to quantify “apical rocking”, has been introduced as a new and integrative parameter for for LV dyssynchrony assessment and as a promising predictor of CRT efficacy[75]. ATM was proposed by Voigt et al[76], who suggested that ATM integrated information about temporal and regional inhomogeneities of LV function and exhibited a significant correlation with the difference between tissue Doppler-derived average strains of the septal and lateral wall. Gürel et al[77] showed that ATM is closely associated with radial dyssynchrony assessed by 2D speckle tracking analysis. Of note, a cut-off value of 2.5 mm for ATM loop could clearly differentiate between patients with and without radial dyssynchrony[77].
Previous studies showed that LV rotational mechanics are altered in patients with advanced HF and prolonged QRS[78]. In those with significant dyssynchrony, not only torsion is reduced but the basal and apical rotation sometimes follows the same direction of rotation[79]. Further, Sade et al[80] showed that LV altered rotational mechanics can be restored by resynchronization therapy. These authors then suggested the use of LV rotational parameters (LV torsion and twist)[80] for predicting CRT responders.
Potential important technical challenges encountered with 2D STE include interpretation of biphasic or multiple peaks in one segment at strain analysis. Seo et al[81] suggested to consider the earliest peak of the segmental strain curve, when more than one peak is evident, as it appears to be the most predictive of response to CRT. Another important limitation of strain analysis has to be faced in presence of akinetic or scar regions, as it could be difficult to get reliable strain curves of these segments. However, LV dyssynchrony is also a 3D phenomenon. Therefore 3D speckle tracking dyssynchrony analysis has been recently introduced and validated. Valuable studies in several studies, 3D-echocardiography has been used to study LV dyssynchrony, assessing volumetric changes in endocardial movement and regional blood displacement[82,83]. Tanaka et al[84] enrolled 54 candidates to CRT and used a 3D speckle tracking system to assess LV dyssynchrony. Radial dyssynchrony was analysed using a 16-segments scheme, expressed as maximal opposing wall delay in time-to-peak strain and standard deviation of time-to-peak strain. The authors found that both parameters significantly correlated with 2D radial strain antero-septal to posterior delay. Furthermore, 3D speckle tracking offers the advantage of identifying the most delayed myocardial region in 3D, in contrast to 2D speckle tracking and TDI analysis.
In fact radial strain 3D speckle tracking analysis offers a complete 3D mechanical activation map with the color-code 3D cine-loop map that provide an immediate visual assessment of the latest activation site among the 16 segments. In another study, Tanaka et al[85] used 3D speckle tracking to study 57 HF patients with prolonged QRS due to either LBBB (group 1) or RV pacing (group 2) with a need to undergo CRT upgrading. They found that the site of earliest mechanical activation was consistently different between the 2 groups (apex 6% in group 1 vs 28% in group 2 respectively), but the most delayed site of activation was similar in the both kind of LV conduction delay. These data supported the use of resynchronization therapy in patients with low EF and a need for pacing.
According to these data, we can conclude that deformation imaging can help to define the presence of intraventricular dyssynchrony better than TDI. Radial speckle tracking and 3D strain analysis appear to be the best method to quantify intraventricular delay and to predict CRT responders.
DEFORMATION IMAGING IN PATIENTS WITH MECHANICAL DYSSYNCHRONY AND FMR
LV dyssynchrony also plays a role in the pathophysiology of FMR. In fact it has been described that intraventricular mechanical dyssynchrony is an important contributor to functional MR[86,87].
Liang et al[11] enrolled patients with EF < 50% and at least mild MR, using TDI to assess global systolic dyssynchrony (maximal difference in time to peak systolic velocity among the 12 LV segments) and regional dyssynchrony (delay between anterolateral and posteromedial papillary muscles insertion regions). These authors concluded that only global dyssynchrony could be considered a FMR determinant, with an incremental value to valve remodeling parameters (tenting area) that play the main role in FMR pathophysiology.
Soyama et al[21] analysed 32 patients with non-ischaemic DCM using TDI derived strain of the papillary muscles; they found FMR to be more frequent in patients with a significant delayed activation of the papillary muscles adjacent LV segments, and concluded that regional dyssynchrony and LV sphericity were independent predictors of FMR.
Agricola et al[88] evaluated 74 patients with chronic LV dysfunction (53% ischemic patients) with varying degrees of MR and suggested that systolic tenting was the main determinant of FMR, as a consequence of global and regional LV remodeling. The authors reported that regional dyssynchrony was independently associated with MR severity, with a minor influence, only in patients with DCM and not in those with ischaemic cardiomyopathy. They also found that the QRS duration had no effect on the severity of FMR. Of note, in this study intraventricular dyssynchrony was expressed as the SD of time-to-peak systolic velocity of 8 (not 12) LV segments. Donal et al[22], using regional strain analysis in 87 patients with DCM, demonstrated that the degree of FMR was determined by mitral orifice morphology, LV features, especially longitudinal contractility (strain of LV mid-lateral wall) and dyssynchrony defined as the delay between the septal and lateral mid-portion strain divided by RR squared root. In addition the authors found that MR was not correlated with interventricular mechanical delay. Also Sardari et al[89] demonstrated that the severity of MR was not correlated with the QRS duration nor with the echocardiographic interventricular dyssynchrony indices in the patients with ischemic or DCM. Moreover, in this study also intraventricular dyssynchrony was not correlated with MR severity. However in this study only Doppler imaging was applied to evaluate LV synchronicity, as neither strain nor time to peak systolic strain analysis were performed.
As for ischemic cardiomyopathy, inferior wall myocardial infarction is known to be associated with more severe MR degree, while anterior myocardial infarction should theoretically be characterized by a higher dyssynchrony index, due to larger infarct dimensions. Patients with anterior acute myocardial infarction (AMI), but not inferior AMI have worse prognosis, and either a larger dyssynchrony index or increased MR severity determine LV remodeling and outcome. Hung et al[90] found that both global and regional dyssynchrony in patients with anterior MI were independently associated with FMR degree. Dyssynchronized myocardial segments were assessed by 3D echo showing an independent impact on FMR grade in a narrow QRS population.
The dyssynchronous contraction of LV papillary muscles is a leading cause of FMR in HF patients, as inferior, posterior and lateral regions are usually identified as the most delayed sites and papillary muscles are regularly located adjacent to lateral and inferior walls. As the majority of the studies regarding papillary muscles dyssynchrony reported different cut off values, the optimal delay for cardia resynchronization has not been established yet. Thus, there is the need for defined cut off values in order to clearly identify the presence of papillary muscles dyssynchrony before CRT in patients with FMR. Tigen et al[91] reported that papillary muscle dyssynchrony with > 60 msec delay (assessed by TDI-derived longitudinal strain) was able to predict a regurgitant volume > 20 mL in DCM patients. Kjordybach et al[92] studied 31 patients with EF lower than 35% of both ischemic and non-ischaemic aetiology and evaluated papillary dyssynchrony by TDI derived time to peak strain. They showed that papillary muscles dyssynchrony was associated with the deformation of mitral apparatus (tenting area), but the haemodynamic consequences of MR (in particular left atrial area) could be better characterized by papillary dyssynchrony only in DCM. Ypenburg et al[13] and Goland et al[93] both assessed dyssynchrony at the papillary muscles insertion sites using radial strain analysis. They reported that MR improvement after CRT was significantly more frequent in patients with baseline dyssynchrony. In 2010, Tigen et al[94] firstly investigated both papillary muscles with 2D speckle tracking from the longitudinal axis in patients with DCM. They found that FMR was significantly correlated with intraventricular dyssynchrony and mitral valve remodeling parameters.
In addition, in this study significant papillary muscles dyssynchrony was found to be the only independent predictor of more than moderate MR. The proposed cut-off value for papillary muscles dyssynchrony (30 ms) predicted a mitral regurgitant volume > 20 mL or EROA > 0.20 cm2 with high sensitivity and specificity.
STE has shown a fundamental role of intraventricular dyssynchrony in determining FMR especially in DCM, rather than in ischemic cardiomyopathy, in which MR severity seems to be more related to mitral valve deformation indexes. Finally the assessment of papillary muscle dyssynchrony can help to identify optimal candidates to CRT, especially among patients with DCM-associated FMR.
THERAPEUTIC CONSIDERATIONS
Medical therapy
The currently accepted optimal pharmacological therapy for HF embraces ACE-inhibitors, diuretics, aldosterone antagonists and beta-blockers[95], and its beneficial effects on HF symptoms in subjects with FMR and LV dysfunction may be remarkable. This combination therapy acts on both neurohormonal activation and the underlying maladaptive pathways, leading to a favourable myocardial remodeling. Several combinations of the above-mentioned drugs are commonly used aiming at reducing the severity of MR and reversing or at least delaying the LV remodeling progression. Afterload-reducing drugs, i.e., ACE-inhibitors, decrease MR regurgitant volume and increase forward output by reducing the pressure gradient between LV and LA. Vasodilators decrease MR regurgitant volume through a systolic unloading on the EROA. Likewise a reduction in MR might be achieved with preload reduction agents, i.e., diuretics, through LV unloading and accordingly a decrease in leaflet tethering. The administration of ACE-inhibitors and beta-blockers is an independent predictor of better long-term survival in subjects with ischemic MR and LV dysfunction since they reduce the progression of LV remodeling and prevent sudden death. Beta-blocker therapy in HF patients reduces all cause mortality, cardiovascular mortality and mortality due to LV systolic dysfunction and sudden death by roughly 31%-39%[96]. In addition, it has been demonstrated that a combined therapy of carvedilol plus ACE-inhibitors decreases FMR by reducing LV dilation[97].
Indications for intervention
FMR surgery is indicated in patients with severe MR and LVEF > 30% undergoing coronary artery bypass grafting (CABG) (recommendation class I, level of evidence C)[98]. It should be considered in patients with moderate MR undergoing CABG (IIa, C) and in symptomatic patients with severe MR, LVEF < 30%, option for revascularization and evidence of myocardial viability (IIa, C). Furthermore FMR surgery may be considered in patients with severe MR and LVEF > 30% with persisting symptoms despite optimal medical management and with low comorbidity, when revascularization is not indicated (IIb, C). In the other patients, optimal medical treatment and extended HF treatment is currently the best option.
Percutaneous mitral valve repair is feasible at low procedural risk in patients with secondary MR and may provide short-term improvement in functional condition and LV function. The percutaneous MitraClip procedure may be considered in patients with symptomatic severe secondary MR despite optimal medical therapy who fulfil the echocardiographic criteria of eligibility, are judged at high surgical risk by a team of cardiologists and cardiac surgeons, and who have a life expectancy greater than one year (IIb, C). A recent metanalysis showed that MitraClip represents an efficacious strategy for patients with HF and severe MR, improving functional class and cardiac remodeling[99].
The management of moderate ischaemic MR in patients undergoing CABG is still unclear. In this circumstance, valve repair is preferable. In patients with low EF, mitral valve surgery should be considered if there is evidence of myocardial viability and if comorbidity is low. Exercise echocardiography should be considered in patients capable of exercising, since exercise-induced dyspnoea and a substantial increase in MR severity and systolic pulmonary artery pressure support mitral surgery in addition to myocardial revascularization.
CRT in patients with FMR
It has been widely demonstrated that CRT decreases mortality and hospitalization rate, improving cardiac function and structure in symptomatic chronic HF patients managed with optimal medical treatment[100], who present severely depressed LVEF (≤ 35%) and complete LBBB (class I recommendation, level of evidence A). In these patients, CRT is superior either to optimal medical therapy or to ICD alone. Efficacy tends to be lower in patients with NYHA class I and IV and in case of non-LBBB morphology with QRS duration < 150 ms. Therefore, in HF patients without LBBB and QRS ≥ 150 ms or LBBB and QRS duration 120-149 ms, CRT is still recommended but considered class IIa or IIb indication[101].
However the improvement in HF symptoms and survival profile after CRT is proportionate to the extent of improvement in LV systolic function. CRT reduces MR severity in patients with chronic HF and FMR. As showed by Upadhyay et al[102], reduction in MR after CRT is considerably related to lesser HF hospitalization and improved survival. In this study baseline MR degree and longer surface QRS to LV lead time were significant predictors of MR change. Furthermore mitral valve was less remodelled in patients with evidence of MR reduction after CRT. Indeed these patients exhibited a lower tenting area and coaptation height than those with stable or worsening MR, suggesting that ventricular geometry improvement could be a mechanism for MR change.
CRT is then responsible for immediate and late reduction in FMR contrasting its pathophysiologic determinants by reducing or virtually eliminating LV dyssynchrony through different mechanisms: (1) increasing “closing forces” (global synchronization); (2) reducing “tethering forces” (local synchronization); (3) reshaping annular geometry and function (local synchronization); and (4) correcting diastolic MR [atrio-ventricular (AV) synchronization].
As for global synchronization, CRT can restore AV and LV synchrony, increasing global LV contraction efficiency and therefore MV coaptation forces. In fact CRT generates a higher pressure-gradient through MV with a consequent rise in trans-mitral closing forces counteracting the tethering forces. Breithardt et al[17] studied 24 HF patients with LBBB and FMR after CRT implantation and confirmed that FMR reduction is directly related to the increased closing force (expressed as LV dP/dt max) that aid mitral valve closure. In addition CRT reduces FMR not only by increasing closing forces but also through “local” synchronization[36]. It was noticed that in CRT responders with FMR reduction, resynchronization was induced at the level of basal and mid-LV segments. At the multivariate analysis mid-LV segments synchrony was the most significant predictor of FMR reduction, suggesting that a more “local” synchronous contraction involving the segments adjacent to papillary muscles could determine FMR improvement. Kanzaki’s et al[38] firstly correlated the immediate reduction in MR after CRT with a more synchronized mechanical activation of papillary muscle insertion points. Further, Goland et al[93], using through 2D Speckle Tracking Radial Strain (2D-RS), showed that a significant delay of time-to-peak 2D-RS in the mid-posterior and inferior segments prior to CRT, along with preserved radial strain in the posterior and inferior segments, were strong predictors of FMR improvement after CRT. Most recently three echocardiographic aspects have been independently associated with FMR change after CRT[103]: Antero-septal to posterior wall radial strain dyssynchrony > 200 ms, non-severe LV dilatation (LV end-systolic diameter index < 29 mm/m2), absence of scar at papillary muscle insertion sites. In the same study the importance of myocardial viability in predicting FMR response was stressed, because CRT can be effective only when responsive viable segments are present. Sénéchal et al[104] evaluated the presence of viability using dobutamine-stress echocardiography before CRT and confirmed that local viability was able to predict acute response to CRT with a proper sensitivity, making local viability an essential precondition for response to CRT. CRT is also thought to improve contraction of the posterior mitral annulus, coordinating the contraction of the segments at the base of the LV. However data are discordant as some studies demonstrate no immediate changes in mitral annular dimensions after CRT and other studies[14] show that annular contraction is correlated to FMR reduction after CRT, although as a minor determinant.
Interestingly all these described effects are pacing dependent as the interruption of CRT causes an immediate recurrence of MR.
According to the timing of response to CRT, there is clear distinction between two phases of MR reduction: (1) immediate MR reduction, occurring suddenly after CRT implantation; and (2) long-term MR reduction, occurring from weeks to months after CRT.
MR may show an immediate improvement after CRT, but the underlying mechanism is not completely clear. It is probably more likely to occur when LV dyssynchrony is mainly related to papillary muscles dyssynchrony. Ypenburg et al[105] showed that CRT may lead to an acute reduction in MR in LV dyssynchrony involving the posterior papillary muscle, as opposed to a late response when the lateral wall is involved. Long-term reduction is the consequence of LV reverse remodeling. In addition, CRT can be associated with acute decrease in resting MR but not in exercise-induced MR. In fact, after CRT only late reversed LV remodeling, restoring mitral apparatus geometry, is associated with a reduction in both resting and exercise-induced MR[106].
Between the two phases of FMR reduction, immediate MR reduction is the major determinant of favourable response to CRT, as it contributes to the acute reduction of volume overload, determining a rapid reverse remodeling. Therefore, immediate MR reduction is a major prognostic determinant after CRT[107].
Surgery
The ideal surgical strategy for the management of ischemic MR is still debated. Peri-operative mortality is higher compared to primary MR, and the long-term prognosis is worse mainly due to the more severe associated comorbidities. Moreover, there is a significant persistence and recurrence rate of MR after valve repair, as McGee demonstrated on a cohort of 585 patients with FMR[108], as well as the absence of prognostic evidences. Severe ischaemic MR is not usually improved by sole revascularization. At the same time the impact of valve surgery on survival remains uncertain because randomized trials are missing and the available observational studies do not draw definite conclusions because of study limitations[109]. With regard to prognosis, most studies failed to demonstrate improved long-term clinical outcome following surgical correction of secondary MR[110,111]. Fattouch et al[112] compared CABG vs CABG plus valve repair in patients with moderate ischemic MR, showing that the addition of MR repair improved functional class, EF, pulmonary artery pressure and LV diameter in the short-term. The study though was not designed to analyse the effect on survival of the addition of valve repair to CABG. When surgery is indicated, valve repair using undersized rigid ring annuloplasty is the first option, offering a low operative risk although it is associated with a significant rate of MR recurrence[113]. Preoperative predictors of recurrent secondary MR after undersized annuloplasty, associated with a worse prognosis, are left ventricular end diastolic diameter, posterior mitral leaflet angle, distal anterior mitral leaflet angle, systolic tenting area, coaptation distance, end-systolic inter-papillary muscle distance, and systolic sphericity index[114]. A meta-analysis of retrospective studies by Vassileva et al[115] suggested better short-term and long-term survival following valve repair compared to its replacement. A recent study on 251 patients with severe ischemic mitral regurgitation randomized to either mitral-valve repair or chordal-sparing replacement revealed no significant difference in LV reverse remodeling or survival at 12 mo; replacement provided a more durable correction of mitral regurgitation, but there was no significant difference in clinical outcomes between-group[116].
Footnotes
Conflict-of-interest statement: The authors declare the absence of any commercial or financial relationships.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Peer-review started: July 27, 2015
First decision: September 22, 2015
Article in press: December 8, 2015
P- Reviewer: De Ponti R, Park YH, Said SAM S- Editor: Ji FF L- Editor: A E- Editor: Lu YJ
References
- 1.Bursi F, Enriquez-Sarano M, Nkomo VT, Jacobsen SJ, Weston SA, Meverden RA, Roger VL. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation. 2005;111:295–301. doi: 10.1161/01.CIR.0000151097.30779.04. [DOI] [PubMed] [Google Scholar]
- 2.Agricola E, Ielasi A, Oppizzi M, Faggiano P, Ferri L, Calabrese A, Vizzardi E, Alfieri O, Margonato A. Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction. Eur J Heart Fail. 2009;11:581–587. doi: 10.1093/eurjhf/hfp051. [DOI] [PubMed] [Google Scholar]
- 3.Lamas GA, Mitchell GF, Flaker GC, Smith SC, Gersh BJ, Basta L, Moyé L, Braunwald E, Pfeffer MA. Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. Circulation. 1997;96:827–833. doi: 10.1161/01.cir.96.3.827. [DOI] [PubMed] [Google Scholar]
- 4.Blondheim DS, Jacobs LE, Kotler MN, Costacurta GA, Parry WR. Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. Am Heart J. 1991;122:763–771. doi: 10.1016/0002-8703(91)90523-k. [DOI] [PubMed] [Google Scholar]
- 5.Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001;103:1759–1764. doi: 10.1161/01.cir.103.13.1759. [DOI] [PubMed] [Google Scholar]
- 6.Kaul S, Spotnitz WD, Glasheen WP, Touchstone DA. Mechanism of ischemic mitral regurgitation. An experimental evaluation. Circulation. 1991;84:2167–2180. doi: 10.1161/01.cir.84.5.2167. [DOI] [PubMed] [Google Scholar]
- 7.Otsuji Y, Handschumacher MD, Liel-Cohen N, Tanabe H, Jiang L, Schwammenthal E, Guerrero JL, Nicholls LA, Vlahakes GJ, Levine RA. Mechanism of ischemic mitral regurgitation with segmental left ventricular dysfunction: three-dimensional echocardiographic studies in models of acute and chronic progressive regurgitation. J Am Coll Cardiol. 2001;37:641–648. doi: 10.1016/s0735-1097(00)01134-7. [DOI] [PubMed] [Google Scholar]
- 8.Agricola E, Oppizzi M, Maisano F, De Bonis M, Schinkel AF, Torracca L, Margonato A, Melisurgo G, Alfieri O. Echocardiographic classification of chronic ischemic mitral regurgitation caused by restricted motion according to tethering pattern. Eur J Echocardiogr. 2004;5:326–334. doi: 10.1016/j.euje.2004.03.001. [DOI] [PubMed] [Google Scholar]
- 9.van der Land V, Germans T, van Dijk J, Zwanenburg JJ, Spreeuwenberg M, Marcus JT, Kamp O, Götte MJ, van Rossum AC. The effect of left bundle branch block on left ventricular remodeling, dyssynchrony and deformation of the mitral valve apparatus: an observational cardiovascular magnetic resonance imaging study. Int J Cardiovasc Imaging. 2007;23:529–536. doi: 10.1007/s10554-006-9187-3. [DOI] [PubMed] [Google Scholar]
- 10.Maurer G, Torres MA, Corday E, Haendchen RV, Meerbaum S. Two-dimensional echocardiographic contrast assessment of pacing-induced mitral regurgitation: relation to altered regional left ventricular function. J Am Coll Cardiol. 1984;3:986–991. doi: 10.1016/s0735-1097(84)80357-5. [DOI] [PubMed] [Google Scholar]
- 11.Liang YJ, Zhang Q, Fang F, Lee AP, Liu M, Yan BP, Lam YY, Chan GC, Yu CM. Incremental value of global systolic dyssynchrony in determining the occurrence of functional mitral regurgitation in patients with left ventricular systolic dysfunction. Eur Heart J. 2013;34:767–774. doi: 10.1093/eurheartj/ehs078. [DOI] [PubMed] [Google Scholar]
- 12.Breithardt OA, Sinha AM, Schwammenthal E, Bidaoui N, Markus KU, Franke A, Stellbrink C. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol. 2003;41:765–770. doi: 10.1016/s0735-1097(02)02937-6. [DOI] [PubMed] [Google Scholar]
- 13.Ypenburg C, Lancellotti P, Tops LF, Bleeker GB, Holman ER, Piérard LA, Schalij MJ, Bax JJ. Acute effects of initiation and withdrawal of cardiac resynchronization therapy on papillary muscle dyssynchrony and mitral regurgitation. J Am Coll Cardiol. 2007;50:2071–2077. doi: 10.1016/j.jacc.2007.08.019. [DOI] [PubMed] [Google Scholar]
- 14.Szymanski P, Klisiewicz A, Hoffman P. Asynchronous movement of mitral annulus: an additional mechanism of ischaemic mitral regurgitation. Clin Cardiol. 2007;30:512–516. doi: 10.1002/clc.20131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Erlebacher JA, Barbarash S. Intraventricular conduction delay and functional mitral regurgitation. Am J Cardiol. 2001;88:A7, 83–86. doi: 10.1016/s0002-9149(01)01595-8. [DOI] [PubMed] [Google Scholar]
- 16.Xiao HB, Lee CH, Gibson DG. Effect of left bundle branch block on diastolic function in dilated cardiomyopathy. Br Heart J. 1991;66:443–447. doi: 10.1136/hrt.66.6.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Breithardt OA, Stellbrink C, Herbots L, Claus P, Sinha AM, Bijnens B, Hanrath P, Sutherland GR. Cardiac resynchronization therapy can reverse abnormal myocardial strain distribution in patients with heart failure and left bundle branch block. J Am Coll Cardiol. 2003;42:486–494. doi: 10.1016/s0735-1097(03)00709-5. [DOI] [PubMed] [Google Scholar]
- 18.Kanzaki H, Bazaz R, Schwartzman D, Dohi K, Sade LE, Gorcsan J. A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: insights from mechanical activation strain mapping. J Am Coll Cardiol. 2004;44:1619–1625. doi: 10.1016/j.jacc.2004.07.036. [DOI] [PubMed] [Google Scholar]
- 19.Linde C, Leclercq C, Rex S, Garrigue S, Lavergne T, Cazeau S, McKenna W, Fitzgerald M, Deharo JC, Alonso C, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol. 2002;40:111–118. doi: 10.1016/s0735-1097(02)01932-0. [DOI] [PubMed] [Google Scholar]
- 20.St John Sutton MG, Plappert T, Abraham WT, Smith AL, DeLurgio DB, Leon AR, Loh E, Kocovic DZ, Fisher WG, Ellestad M, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation. 2003;107:1985–1990. doi: 10.1161/01.CIR.0000065226.24159.E9. [DOI] [PubMed] [Google Scholar]
- 21.Soyama A, Kono T, Mishima T, Morita H, Ito T, Suwa M, Kitaura Y. Intraventricular dyssynchrony may play a role in the development of mitral regurgitation in dilated cardiomyopathy. J Card Fail. 2005;11:631–637. doi: 10.1016/j.cardfail.2005.06.438. [DOI] [PubMed] [Google Scholar]
- 22.Donal E, De Place C, Kervio G, Bauer F, Gervais R, Leclercq C, Mabo P, Daubert JC. Mitral regurgitation in dilated cardiomyopathy: value of both regional left ventricular contractility and dyssynchrony. Eur J Echocardiogr. 2009;10:133–138. doi: 10.1093/ejechocard/jen188. [DOI] [PubMed] [Google Scholar]
- 23.Konstantinou DM, Papadopoulou K, Giannakoulas G, Kamperidis V, Dalamanga EG, Damvopoulou E, Parcharidou DG, Karamitsos TD, Karvounis HI. Determinants of functional mitral regurgitation severity in patients with ischemic cardiomyopathy versus nonischemic dilated cardiomyopathy. Echocardiography. 2014;31:21–28. doi: 10.1111/echo.12304. [DOI] [PubMed] [Google Scholar]
- 24.Hung J, Otsuji Y, Handschumacher MD, Schwammenthal E, Levine RA. Mechanism of dynamic regurgitant orifice area variation in functional mitral regurgitation: physiologic insights from the proximal flow convergence technique. J Am Coll Cardiol. 1999;33:538–545. doi: 10.1016/s0735-1097(98)00570-1. [DOI] [PubMed] [Google Scholar]
- 25.Ennezat PV, Maréchaux S, Le Tourneau T, Lamblin N, Bauters C, Van Belle E, Gal B, Kacet S, Asseman P, Deklunder G, et al. Myocardial asynchronism is a determinant of changes in functional mitral regurgitation severity during dynamic exercise in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Eur Heart J. 2006;27:679–683. doi: 10.1093/eurheartj/ehi682. [DOI] [PubMed] [Google Scholar]
- 26.Perk G, Tunick PA, Kronzon I. Non-Doppler two-dimensional strain imaging by echocardiography--from technical considerations to clinical applications. J Am Soc Echocardiogr. 2007;20:234–243. doi: 10.1016/j.echo.2006.08.023. [DOI] [PubMed] [Google Scholar]
- 27.Blessberger H, Binder T. NON-invasive imaging: Two dimensional speckle tracking echocardiography: basic principles. Heart. 2010;96:716–722. doi: 10.1136/hrt.2007.141002. [DOI] [PubMed] [Google Scholar]
- 28.Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, Gentile F, Nesser HJ, Khandheria B, Narula J, Sengupta PP. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr. 2010;23:351–369; quiz 453-455. doi: 10.1016/j.echo.2010.02.015. [DOI] [PubMed] [Google Scholar]
- 29.van Dalen BM, Soliman OI, Vletter WB, Kauer F, van der Zwaan HB, ten Cate FJ, Geleijnse ML. Feasibility and reproducibility of left ventricular rotation parameters measured by speckle tracking echocardiography. Eur J Echocardiogr. 2009;10:669–676. doi: 10.1093/ejechocard/jep036. [DOI] [PubMed] [Google Scholar]
- 30.Amundsen BH, Helle-Valle T, Edvardsen T, Torp H, Crosby J, Lyseggen E, Støylen A, Ihlen H, Lima JA, Smiseth OA, et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J Am Coll Cardiol. 2006;47:789–793. doi: 10.1016/j.jacc.2005.10.040. [DOI] [PubMed] [Google Scholar]
- 31.Mondillo S, Galderisi M, Mele D, Cameli M, Lomoriello VS, Zacà V, Ballo P, D’Andrea A, Muraru D, Losi M, et al. Speckle-tracking echocardiography: a new technique for assessing myocardial function. J Ultrasound Med. 2011;30:71–83. doi: 10.7863/jum.2011.30.1.71. [DOI] [PubMed] [Google Scholar]
- 32.Teske AJ, De Boeck BW, Melman PG, Sieswerda GT, Doevendans PA, Cramer MJ. Echocardiographic quantification of myocardial function using tissue deformation imaging, a guide to image acquisition and analysis using tissue Doppler and speckle tracking. Cardiovasc Ultrasound. 2007;5:27. doi: 10.1186/1476-7120-5-27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Brown J, Jenkins C, Marwick TH. Use of myocardial strain to assess global left ventricular function: a comparison with cardiac magnetic resonance and 3-dimensional echocardiography. Am Heart J. 2009;157:102.e1–102.e5. doi: 10.1016/j.ahj.2008.08.032. [DOI] [PubMed] [Google Scholar]
- 34.Cameli M, Caputo M, Mondillo S, Ballo P, Palmerini E, Lisi M, Marino E, Galderisi M. Feasibility and reference values of left atrial longitudinal strain imaging by two-dimensional speckle tracking. Cardiovasc Ultrasound. 2009;7:6. doi: 10.1186/1476-7120-7-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Horton KD, Meece RW, Hill JC. Assessment of the right ventricle by echocardiography: a primer for cardiac sonographers. J Am Soc Echocardiogr. 2009;22:776–792; quiz 861-862. doi: 10.1016/j.echo.2009.04.027. [DOI] [PubMed] [Google Scholar]
- 36.Saito K, Okura H, Watanabe N, Hayashida A, Obase K, Imai K, Maehama T, Kawamoto T, Neishi Y, Yoshida K. Comprehensive evaluation of left ventricular strain using speckle tracking echocardiography in normal adults: comparison of three-dimensional and two-dimensional approaches. J Am Soc Echocardiogr. 2009;22:1025–1030. doi: 10.1016/j.echo.2009.05.021. [DOI] [PubMed] [Google Scholar]
- 37.Notomi Y, Lysyansky P, Setser RM, Shiota T, Popović ZB, Martin-Miklovic MG, Weaver JA, Oryszak SJ, Greenberg NL, White RD, et al. Measurement of ventricular torsion by two-dimensional ultrasound speckle tracking imaging. J Am Coll Cardiol. 2005;45:2034–2041. doi: 10.1016/j.jacc.2005.02.082. [DOI] [PubMed] [Google Scholar]
- 38.Takeuchi M, Nakai H, Kokumai M, Nishikage T, Otani S, Lang RM. Age-related changes in left ventricular twist assessed by two-dimensional speckle-tracking imaging. J Am Soc Echocardiogr. 2006;19:1077–1084. doi: 10.1016/j.echo.2006.04.011. [DOI] [PubMed] [Google Scholar]
- 39.Choi JO, Cho SW, Song YB, Cho SJ, Song BG, Lee SC, Park SW. Longitudinal 2D strain at rest predicts the presence of left main and three vessel coronary artery disease in patients without regional wall motion abnormality. Eur J Echocardiogr. 2009;10:695–701. doi: 10.1093/ejechocard/jep041. [DOI] [PubMed] [Google Scholar]
- 40.Voigt JU, Nixdorff U, Bogdan R, Exner B, Schmiedehausen K, Platsch G, Kuwert T, Daniel WG, Flachskampf FA. Comparison of deformation imaging and velocity imaging for detecting regional inducible ischaemia during dobutamine stress echocardiography. Eur Heart J. 2004;25:1517–1525. doi: 10.1016/j.ehj.2004.05.014. [DOI] [PubMed] [Google Scholar]
- 41.Kosmala W, Plaksej R, Strotmann JM, Weigel C, Herrmann S, Niemann M, Mende H, Störk S, Angermann CE, Wagner JA, et al. Progression of left ventricular functional abnormalities in hypertensive patients with heart failure: an ultrasonic two-dimensional speckle tracking study. J Am Soc Echocardiogr. 2008;21:1309–1317. doi: 10.1016/j.echo.2008.10.006. [DOI] [PubMed] [Google Scholar]
- 42.Liu YW, Tsai WC, Su CT, Lin CC, Chen JH. Evidence of left ventricular systolic dysfunction detected by automated function imaging in patients with heart failure and preserved left ventricular ejection fraction. J Card Fail. 2009;15:782–789. doi: 10.1016/j.cardfail.2009.05.006. [DOI] [PubMed] [Google Scholar]
- 43.Stanton T, Leano R, Marwick TH. Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring. Circ Cardiovasc Imaging. 2009;2:356–364. doi: 10.1161/CIRCIMAGING.109.862334. [DOI] [PubMed] [Google Scholar]
- 44.Mele D, Toselli T, Dal Monte A, Guardigli G, Ceconi C, Ferrari R. [Beyond dyssynchrony: what are the factors determining the response to cardiac resynchronization therapy?] G Ital Cardiol (Rome) 2008;9:320–337. [PubMed] [Google Scholar]
- 45.Conca C, Faletra FF, Miyazaki C, Oh J, Mantovani A, Klersy C, Sorgente A, Pedrazzini GB, Pasotti E, Moccetti T, et al. Echocardiographic parameters of mechanical synchrony in healthy individuals. Am J Cardiol. 2009;103:136–142. doi: 10.1016/j.amjcard.2008.08.039. [DOI] [PubMed] [Google Scholar]
- 46.Tops LF, Delgado V, Bax JJ. The role of speckle tracking strain imaging in cardiac pacing. Echocardiography. 2009;26:315–323. doi: 10.1111/j.1540-8175.2008.00865.x. [DOI] [PubMed] [Google Scholar]
- 47.Nesser HJ, Winter S. Speckle tracking in the evaluation of left ventricular dyssynchrony. Echocardiography. 2009;26:324–336. doi: 10.1111/j.1540-8175.2008.00866.x. [DOI] [PubMed] [Google Scholar]
- 48.Crosby J, Amundsen BH, Hergum T, Remme EW, Langeland S, Torp H. 3-D speckle tracking for assessment of regional left ventricular function. Ultrasound Med Biol. 2009;35:458–471. doi: 10.1016/j.ultrasmedbio.2008.09.011. [DOI] [PubMed] [Google Scholar]
- 49.Elen A, Choi HF, Loeckx D, Gao H, Claus P, Suetens P, Maes F, D’hooge J. Three-dimensional cardiac strain estimation using spatio-temporal elastic registration of ultrasound images: a feasibility study. IEEE Trans Med Imaging. 2008;27:1580–1591. doi: 10.1109/TMI.2008.2004420. [DOI] [PubMed] [Google Scholar]
- 50.Takeguchi T, Nishiura M, Abe Y, Ohuchi H, Kawagishi T. Practical considerations for a method of rapid cardiac function analysis based on three-dimensional speckle tracking in a three-dimensional diagnostic ultrasound system. J Med Ultrason. 2010;37:41–49. doi: 10.1007/s10396-009-0249-8. [DOI] [PubMed] [Google Scholar]
- 51.Enriquez-Sarano M, Schaff HV, Orszulak TA, Bailey KR, Tajik AJ, Frye RL. Congestive heart failure after surgical correction of mitral regurgitation. A long-term study. Circulation. 1995;92:2496–2503. doi: 10.1161/01.cir.92.9.2496. [DOI] [PubMed] [Google Scholar]
- 52.Agricola E, Galderisi M, Oppizzi M, Schinkel AF, Maisano F, De Bonis M, Margonato A, Maseri A, Alfieri O. Pulsed tissue Doppler imaging detects early myocardial dysfunction in asymptomatic patients with severe mitral regurgitation. Heart. 2004;90:406–410. doi: 10.1136/hrt.2002.009621. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Lancellotti P, Cosyns B, Zacharakis D, Attena E, Van Camp G, Gach O, Radermecker M, Piérard LA. Importance of left ventricular longitudinal function and functional reserve in patients with degenerative mitral regurgitation: assessment by two-dimensional speckle tracking. J Am Soc Echocardiogr. 2008;21:1331–1336. doi: 10.1016/j.echo.2008.09.023. [DOI] [PubMed] [Google Scholar]
- 54.Moonen M, Lancellotti P, Zacharakis D, Pierard L. The value of 2D strain imaging during stress testing. Echocardiography. 2009;26:307–314. doi: 10.1111/j.1540-8175.2008.00864.x. [DOI] [PubMed] [Google Scholar]
- 55.Boldt A, Wetzel U, Lauschke J, Weigl J, Gummert J, Hindricks G, Kottkamp H, Dhein S. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart. 2004;90:400–405. doi: 10.1136/hrt.2003.015347. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Kizer JR, Bella JN, Palmieri V, Liu JE, Best LG, Lee ET, Roman MJ, Devereux RB. Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS) Am Heart J. 2006;151:412–418. doi: 10.1016/j.ahj.2005.04.031. [DOI] [PubMed] [Google Scholar]
- 57.Cameli M, Lisi M, Righini FM, Focardi M, Alfieri O, Mondillo S. Left atrial speckle tracking analysis in patients with mitral insufficiency and history of paroxysmal atrial fibrillation. Int J Cardiovasc Imaging. 2012;28:1663–1670. doi: 10.1007/s10554-011-9987-y. [DOI] [PubMed] [Google Scholar]
- 58.Notabartolo D, Merlino JD, Smith AL, DeLurgio DB, Vera FV, Easley KA, Martin RP, León AR. Usefulness of the peak velocity difference by tissue Doppler imaging technique as an effective predictor of response to cardiac resynchronization therapy. Am J Cardiol. 2004;94:817–820. doi: 10.1016/j.amjcard.2004.05.072. [DOI] [PubMed] [Google Scholar]
- 59.Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, van der Wall EE, Schalij MJ. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44:1834–1840. doi: 10.1016/j.jacc.2004.08.016. [DOI] [PubMed] [Google Scholar]
- 60.Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008;117:2608–2616. doi: 10.1161/CIRCULATIONAHA.107.743120. [DOI] [PubMed] [Google Scholar]
- 61.Suffoletto MS, Dohi K, Cannesson M, Saba S, Gorcsan J. Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy. Circulation. 2006;113:960–968. doi: 10.1161/CIRCULATIONAHA.105.571455. [DOI] [PubMed] [Google Scholar]
- 62.Gorcsan J, Tanabe M, Bleeker GB, Suffoletto MS, Thomas NC, Saba S, Tops LF, Schalij MJ, Bax JJ. Combined longitudinal and radial dyssynchrony predicts ventricular response after resynchronization therapy. J Am Coll Cardiol. 2007;50:1476–1483. doi: 10.1016/j.jacc.2007.06.043. [DOI] [PubMed] [Google Scholar]
- 63.Bank AJ, Kaufman CL, Kelly AS, Burns KV, Adler SW, Rector TS, Goldsmith SR, Olivari MT, Tang C, Nelson L, et al. Results of the Prospective Minnesota Study of ECHO/TDI in Cardiac Resynchronization Therapy (PROMISE-CRT) study. J Card Fail. 2009;15:401–409. doi: 10.1016/j.cardfail.2008.12.009. [DOI] [PubMed] [Google Scholar]
- 64.Gorcsan J, Oyenuga O, Habib PJ, Tanaka H, Adelstein EC, Hara H, McNamara DM, Saba S. Relationship of echocardiographic dyssynchrony to long-term survival after cardiac resynchronization therapy. Circulation. 2010;122:1910–1918. doi: 10.1161/CIRCULATIONAHA.110.954768. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Tanaka H, Nesser HJ, Buck T, Oyenuga O, Jánosi RA, Winter S, Saba S, Gorcsan J. Dyssynchrony by speckle-tracking echocardiography and response to cardiac resynchronization therapy: results of the Speckle Tracking and Resynchronization (STAR) study. Eur Heart J. 2010;31:1690–1700. doi: 10.1093/eurheartj/ehq213. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Ypenburg C, van Bommel RJ, Delgado V, Mollema SA, Bleeker GB, Boersma E, Schalij MJ, Bax JJ. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol. 2008;52:1402–1409. doi: 10.1016/j.jacc.2008.06.046. [DOI] [PubMed] [Google Scholar]
- 67.Lim P, Buakhamsri A, Popovic ZB, Greenberg NL, Patel D, Thomas JD, Grimm RA. Longitudinal strain delay index by speckle tracking imaging: a new marker of response to cardiac resynchronization therapy. Circulation. 2008;118:1130–1137. doi: 10.1161/CIRCULATIONAHA.107.750190. [DOI] [PubMed] [Google Scholar]
- 68.Shi H, Shu X, Wang F, Cui J, Chen H, Sun B, Liu S. Longitudinal two-dimensional strain rate imaging: a potential approach to predict the response to cardiac resynchronization therapy. Int J Cardiovasc Imaging. 2009;25:677–687. doi: 10.1007/s10554-009-9480-z. [DOI] [PubMed] [Google Scholar]
- 69.Ma CY, Liu S, Yang J, Tang L, Zhang LM, Li N, Yu B. Evaluation of global longitudinal strain of left ventricle and regional longitudinal strain in the region of left ventricular leads predicts the response to cardiac resynchronization therapy in patients with ischemic heart failure. Cell Biochem Biophys. 2014;70:143–148. doi: 10.1007/s12013-014-9870-2. [DOI] [PubMed] [Google Scholar]
- 70.Becker M, Kramann R, Franke A, Breithardt OA, Heussen N, Knackstedt C, Stellbrink C, Schauerte P, Kelm M, Hoffmann R. Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodelling. A circumferential strain analysis based on 2D echocardiography. Eur Heart J. 2007;28:1211–1220. doi: 10.1093/eurheartj/ehm034. [DOI] [PubMed] [Google Scholar]
- 71.Delgado V, Ypenburg C, van Bommel RJ, Tops LF, Mollema SA, Marsan NA, Bleeker GB, Schalij MJ, Bax JJ. Assessment of left ventricular dyssynchrony by speckle tracking strain imaging comparison between longitudinal, circumferential, and radial strain in cardiac resynchronization therapy. J Am Coll Cardiol. 2008;51:1944–1952. doi: 10.1016/j.jacc.2008.02.040. [DOI] [PubMed] [Google Scholar]
- 72.Lardo AC, Abraham TP, Kass DA. Magnetic resonance imaging assessment of ventricular dyssynchrony: current and emerging concepts. J Am Coll Cardiol. 2005;46:2223–2228. doi: 10.1016/j.jacc.2005.09.015. [DOI] [PubMed] [Google Scholar]
- 73.Bilchick KC, Dimaano V, Wu KC, Helm RH, Weiss RG, Lima JA, Berger RD, Tomaselli GF, Bluemke DA, Halperin HR, et al. Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy. JACC Cardiovasc Imaging. 2008;1:561–568. doi: 10.1016/j.jcmg.2008.04.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Risum N, Jons C, Olsen NT, Fritz-Hansen T, Bruun NE, Hojgaard MV, Valeur N, Kronborg MB, Kisslo J, Sogaard P. Simple regional strain pattern analysis to predict response to cardiac resynchronization therapy: rationale, initial results, and advantages. Am Heart J. 2012;163:697–704. doi: 10.1016/j.ahj.2012.01.025. [DOI] [PubMed] [Google Scholar]
- 75.Szulik M, Tillekaerts M, Vangeel V, Ganame J, Willems R, Lenarczyk R, Rademakers F, Kalarus Z, Kukulski T, Voigt JU. Assessment of apical rocking: a new, integrative approach for selection of candidates for cardiac resynchronization therapy. Eur J Echocardiogr. 2010;11:863–869. doi: 10.1093/ejechocard/jeq081. [DOI] [PubMed] [Google Scholar]
- 76.Voigt JU, Schneider TM, Korder S, Szulik M, Gürel E, Daniel WG, Rademakers F, Flachskampf FA. Apical transverse motion as surrogate parameter to determine regional left ventricular function inhomogeneities: a new, integrative approach to left ventricular asynchrony assessment. Eur Heart J. 2009;30:959–968. doi: 10.1093/eurheartj/ehp062. [DOI] [PubMed] [Google Scholar]
- 77.Gürel E, Tigen K, Karaahmet T, Dündar C, Güler A, Başaran Y. Apical transverse motion is associated with speckle-tracking radial dyssynchrony in patients with non-ischemic dilated cardiomyopathy. Anatol J Cardiol. 2015;15:620–625. doi: 10.5152/akd.2014.5607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Bertini M, Nucifora G, Marsan NA, Delgado V, van Bommel RJ, Boriani G, Biffi M, Holman ER, Van der Wall EE, Schalij MJ, et al. Left ventricular rotational mechanics in acute myocardial infarction and in chronic (ischemic and nonischemic) heart failure patients. Am J Cardiol. 2009;103:1506–1512. doi: 10.1016/j.amjcard.2009.02.010. [DOI] [PubMed] [Google Scholar]
- 79.Setser RM, Kasper JM, Lieber ML, Starling RC, McCarthy PM, White RD. Persistent abnormal left ventricular systolic torsion in dilated cardiomyopathy after partial left ventriculectomy. J Thorac Cardiovasc Surg. 2003;126:48–55. doi: 10.1016/s0022-5223(03)00050-3. [DOI] [PubMed] [Google Scholar]
- 80.Sade LE, Demir O, Atar I, Müderrisoglu H, Ozin B. Effect of mechanical dyssynchrony and cardiac resynchronization therapy on left ventricular rotational mechanics. Am J Cardiol. 2008;101:1163–1169. doi: 10.1016/j.amjcard.2007.11.069. [DOI] [PubMed] [Google Scholar]
- 81.Seo Y, Ito H, Nakatani S, Takami M, Naito S, Shiga T, Ando K, Wakayama Y, Aonuma K. The role of echocardiography in predicting responders to cardiac resynchronization therapy. Circ J. 2011;75:1156–1163. doi: 10.1253/circj.cj-10-0861. [DOI] [PubMed] [Google Scholar]
- 82.van Dijk J, Knaapen P, Russel IK, Hendriks T, Allaart CP, de Cock CC, Kamp O. Mechanical dyssynchrony by 3D echo correlates with acute haemodynamic response to biventricular pacing in heart failure patients. Europace. 2008;10:63–68. doi: 10.1093/europace/eum262. [DOI] [PubMed] [Google Scholar]
- 83.Takeuchi M, Jacobs A, Sugeng L, Nishikage T, Nakai H, Weinert L, Salgo IS, Lang RM. Assessment of left ventricular dyssynchrony with real-time 3-dimensional echocardiography: comparison with Doppler tissue imaging. J Am Soc Echocardiogr. 2007;20:1321–1329. doi: 10.1016/j.echo.2007.05.001. [DOI] [PubMed] [Google Scholar]
- 84.Tanaka H, Hara H, Saba S, Gorcsan J. Usefulness of three-dimensional speckle tracking strain to quantify dyssynchrony and the site of latest mechanical activation. Am J Cardiol. 2010;105:235–242. doi: 10.1016/j.amjcard.2009.09.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Tanaka H, Hara H, Adelstein EC, Schwartzman D, Saba S, Gorcsan J. Comparative mechanical activation mapping of RV pacing to LBBB by 2D and 3D speckle tracking and association with response to resynchronization therapy. JACC Cardiovasc Imaging. 2010;3:461–471. doi: 10.1016/j.jcmg.2009.12.014. [DOI] [PubMed] [Google Scholar]
- 86.Zhang Q, Yu CM. Clinical implication of mechanical dyssynchrony in heart failure. J Cardiovasc Ultrasound. 2012;20:117–123. doi: 10.4250/jcu.2012.20.3.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Vinereanu D. Mitral regurgitation and cardiac resynchronization therapy. Echocardiography. 2008;25:1155–1166. doi: 10.1111/j.1540-8175.2008.00781.x. [DOI] [PubMed] [Google Scholar]
- 88.Agricola E, Oppizzi M, Galderisi M, Pisani M, Meris A, Pappone C, Margonato A. Role of regional mechanical dyssynchrony as a determinant of functional mitral regurgitation in patients with left ventricular systolic dysfunction. Heart. 2006;92:1390–1395. doi: 10.1136/hrt.2005.082115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Sardari A, Ashraf H, Khorsand M, Zoroufian A, Sahebjam M, Jalali A, Sadeghian H. Correlation between Mitral Regurgitation and Myocardial Mechanical Dyssynchrony and QRS Duration in Patients with Cardiomyopathy. J Tehran Heart Cent. 2014;9:147–152. [PMC free article] [PubMed] [Google Scholar]
- 90.Hung CL, Tien SL, Lo CI, Hung TC, Yeh HI, Wang YS. The incremental value of regional dyssynchrony in determining functional mitral regurgitation beyond left ventricular geometry after narrow QRS anterior myocardial infarction: a real time three-dimensional echocardiography study. Echocardiography. 2011;28:665–675. doi: 10.1111/j.1540-8175.2011.01403.x. [DOI] [PubMed] [Google Scholar]
- 91.Tigen K, Karaahmet T, Gürel E, Cevik C, Otahbachi M, Pala S, Tanalp AC, Mutlu B, Başaran Y. Papillary muscle dyssynchrony as a cause of functional mitral regurgitation in non-ischemic dilated cardiomyopathy patients with narrow QRS complexes. Anadolu Kardiyol Derg. 2009;9:196–203. [PubMed] [Google Scholar]
- 92.Kordybach M, Kowalski M, Kowalik E, Hoffman P. Papillary muscle dyssynchrony in patients with systolic left ventricular dysfunction. Scand Cardiovasc J. 2012;46:16–22. doi: 10.3109/14017431.2011.636452. [DOI] [PubMed] [Google Scholar]
- 93.Goland S, Rafique AM, Mirocha J, Siegel RJ, Naqvi TZ. Reduction in mitral regurgitation in patients undergoing cardiac resynchronization treatment: assessment of predictors by two-dimensional radial strain echocardiography. Echocardiography. 2009;26:420–430. doi: 10.1111/j.1540-8175.2008.00823.x. [DOI] [PubMed] [Google Scholar]
- 94.Tigen K, Karaahmet T, Dundar C, Guler A, Cevik C, Basaran O, Kirma C, Basaran Y. The importance of papillary muscle dyssynchrony in predicting the severity of functional mitral regurgitation in patients with non-ischaemic dilated cardiomyopathy: a two-dimensional speckle-tracking echocardiography study. Eur J Echocardiogr. 2010;11:671–676. doi: 10.1093/ejechocard/jeq040. [DOI] [PubMed] [Google Scholar]
- 95.McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803–869. doi: 10.1093/eurjhf/hfs105. [DOI] [PubMed] [Google Scholar]
- 96.Bonet S, Agustí A, Arnau JM, Vidal X, Diogène E, Galve E, Laporte JR. Beta-adrenergic blocking agents in heart failure: benefits of vasodilating and non-vasodilating agents according to patients’ characteristics: a meta-analysis of clinical trials. Arch Intern Med. 2000;160:621–627. doi: 10.1001/archinte.160.5.621. [DOI] [PubMed] [Google Scholar]
- 97.Capomolla S, Febo O, Gnemmi M, Riccardi G, Opasich C, Caporotondi A, Mortara A, Pinna GD, Cobelli F. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J. 2000;139:596–608. doi: 10.1016/s0002-8703(00)90036-x. [DOI] [PubMed] [Google Scholar]
- 98.McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787–1847. doi: 10.1093/eurheartj/ehs104. [DOI] [PubMed] [Google Scholar]
- 99.D'ascenzo F, Moretti C, Marra WG, Montefusco A, Omede P, Taha S, Castagno D, Gaemperli O, Taramasso M, Frea S, et al. Meta-analysis of the usefulness of Mitraclip in patients with functional mitral regurgitation. Am J Cardiol. 2015;116:325–331. doi: 10.1016/j.amjcard.2015.04.025. [DOI] [PubMed] [Google Scholar]
- 100.Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–1549. doi: 10.1056/NEJMoa050496. [DOI] [PubMed] [Google Scholar]
- 101.Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NA, Ferguson TB, Hammill SC, Karasik PE, Link MS, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected] Circulation. 2012;126:1784–1800. doi: 10.1161/CIR.0b013e3182618569. [DOI] [PubMed] [Google Scholar]
- 102.Upadhyay GA, Chatterjee NA, Kandala J, Friedman DJ, Park MY, Tabtabai SR, Hung J, Singh JP. Assessing mitral regurgitation in the prediction of clinical outcome after cardiac resynchronization therapy. Heart Rhythm. 2015;12:1201–1208. doi: 10.1016/j.hrthm.2015.02.022. [DOI] [PubMed] [Google Scholar]
- 103.Onishi T, Onishi T, Marek JJ, Ahmed M, Haberman SC, Oyenuga O, Adelstein E, Schwartzman D, Saba S, Gorcsan J. Mechanistic features associated with improvement in mitral regurgitation after cardiac resynchronization therapy and their relation to long-term patient outcome. Circ Heart Fail. 2013;6:685–693. doi: 10.1161/CIRCHEARTFAILURE.112.000112. [DOI] [PubMed] [Google Scholar]
- 104.Sénéchal M, Lancellotti P, Garceau P, Champagne J, Dubois M, Magne J, Blier L, Molin F, Philippon F, Dumesnil JG, et al. Usefulness and limitation of dobutamine stress echocardiography to predict acute response to cardiac resynchronization therapy. Echocardiography. 2010;27:50–57. doi: 10.1111/j.1540-8175.2009.00962.x. [DOI] [PubMed] [Google Scholar]
- 105.Ypenburg C, Lancellotti P, Tops LF, Boersma E, Bleeker GB, Holman ER, Thomas JD, Schalij MJ, Piérard LA, Bax JJ. Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy. Eur Heart J. 2008;29:757–765. doi: 10.1093/eurheartj/ehn063. [DOI] [PubMed] [Google Scholar]
- 106.Madaric J, Vanderheyden M, Van Laethem C, Verhamme K, Feys A, Goethals M, Verstreken S, Geelen P, Penicka M, De Bruyne B, et al. Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance. Eur Heart J. 2007;28:2134–2141. doi: 10.1093/eurheartj/ehm126. [DOI] [PubMed] [Google Scholar]
- 107.Di Biase L, Auricchio A, Mohanty P, Bai R, Kautzner J, Pieragnoli P, Regoli F, Sorgente A, Spinucci G, Ricciardi G, et al. Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. Europace. 2011;13:829–838. doi: 10.1093/europace/eur047. [DOI] [PubMed] [Google Scholar]
- 108.McGee EC, Gillinov AM, Blackstone EH, Rajeswaran J, Cohen G, Najam F, Shiota T, Sabik JF, Lytle BW, McCarthy PM, et al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2004;128:916–924. doi: 10.1016/j.jtcvs.2004.07.037. [DOI] [PubMed] [Google Scholar]
- 109.Fattouch K, Sampognaro R, Speziale G, Salardino M, Novo G, Caruso M, Novo S, Ruvolo G. Impact of moderate ischemic mitral regurgitation after isolated coronary artery bypass grafting. Ann Thorac Surg. 2010;90:1187–1194. doi: 10.1016/j.athoracsur.2010.03.103. [DOI] [PubMed] [Google Scholar]
- 110.Mihaljevic T, Lam BK, Rajeswaran J, Takagaki M, Lauer MS, Gillinov AM, Blackstone EH, Lytle BW. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol. 2007;49:2191–2201. doi: 10.1016/j.jacc.2007.02.043. [DOI] [PubMed] [Google Scholar]
- 111.Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol. 2005;45:381–387. doi: 10.1016/j.jacc.2004.09.073. [DOI] [PubMed] [Google Scholar]
- 112.Fattouch K, Guccione F, Sampognaro R, Panzarella G, Corrado E, Navarra E, Calvaruso D, Ruvolo G. POINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial. J Thorac Cardiovasc Surg. 2009;138:278–285. doi: 10.1016/j.jtcvs.2008.11.010. [DOI] [PubMed] [Google Scholar]
- 113.Braun J, Bax JJ, Versteegh MI, Voigt PG, Holman ER, Klautz RJ, Boersma E, Dion RA. Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in ischemic mitral regurgitation. Eur J Cardiothorac Surg. 2005;27:847–853. doi: 10.1016/j.ejcts.2004.12.031. [DOI] [PubMed] [Google Scholar]
- 114.Ciarka A, Braun J, Delgado V, Versteegh M, Boersma E, Klautz R, Dion R, Bax JJ, Van de Veire N. Predictors of mitral regurgitation recurrence in patients with heart failure undergoing mitral valve annuloplasty. Am J Cardiol. 2010;106:395–401. doi: 10.1016/j.amjcard.2010.03.042. [DOI] [PubMed] [Google Scholar]
- 115.Vassileva CM, Boley T, Markwell S, Hazelrigg S. Meta-analysis of short-term and long-term survival following repair versus replacement for ischemic mitral regurgitation. Eur J Cardiothorac Surg. 2011;39:295–303. doi: 10.1016/j.ejcts.2010.06.034. [DOI] [PubMed] [Google Scholar]
- 116.Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, Smith PK, Hung JW, Blackstone EH, Puskas JD, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med. 2014;370:23–32. doi: 10.1056/NEJMoa1312808. [DOI] [PMC free article] [PubMed] [Google Scholar]